Virginia House Committee Unanimously Advances Bill to Update Medical Marijuana Labels and Allow Home Delivery

Virginia’s House General Laws Committee voted 21 to 0 today to advance HB 391, a proposal to revise medical cannabis product labeling requirements and explicitly allowing home delivery to registered patients. The committee approved the bill the same day it voted 19 to 2 to advance a proposal that would legalize recreational cannabis sales. Filed by Delegate Carrie Coyner Askew (R) earlier this month, the measure focuses on clarifying how potency information must appear on medical marijuana products and establishing clear rules for where deliveries can and cannot occur.

Under current law, medical marijuana product labels must include the total percentage and milligrams of THC and CBD in the product, along with the milligrams of each per serving. HB 391 modifies this by requiring pharmaceutical processors to tailor label information based on product type.

For edible and topical marijuana products, labels would be required to list the total milligrams of THC and CBD in the product, as well as the milligrams of each per serving. For inhalable marijuana products, labels would instead be required to list the total percentage of THC and CBD contained in the product.

In addition to labeling changes, the bill would explicitly allow pharmaceutical processors and cannabis dispensing facilities to deliver medical marijuana products directly to a patient’s residence, including temporary residences and places of business. The measure outlines several locations where delivery would remain prohibited, including military bases, child day centers, schools, correctional facilities, the State Capitol, and public gathering places such as sporting events, festivals, fairs, concerts, races, and public transportation terminals.

The bill also specifies that all delivery activity—whether conducted by an employee or a delivery agent—must comply with all relevant laws and regulations. The Virginia Cannabis Control Authority would be given the authority to suspend or revoke the delivery privileges of any employee or agent who fails to comply.

According to the state’s fiscal impact statement, the proposal is not expected to have any material impact on state finances or agency operations.

With unanimous committee support, HB 391 now moves forward in the legislative process as lawmakers continue to refine the structure and accessibility of Virginia’s medical marijuana program.